Dr
Sofie
McPherson

Patent Director

London Office

Electronics

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Sofie is a Chartered UK and European Patent Attorney and her work includes providing strategic advice on how to protect inventions and to deliver solutions that are commercially focused and relevant to the client. She easily adapts to her clients’ ways of working and takes a proactive role to support their needs.

Much of Sofie’s work is based around software in various industries, and she has particular experience of software in healthcare, finance, online gaming, mobile phone apps, live events displays, Internet-of Things, Machine-to-Machine and graphical user interface. Sofie also has great experience in Standard related work, in particular telecoms and 3GPP, and understands the technical and commercial relationship between technical standards, patents and patent applications. Much of Sofie’s experience has been in relation to security related inventions in 4G and 5G.

Sofie graduated with a First class degree in Materials Engineering in Medicine, and has a PhD in Biomaterials with focus on developing and characterisation of synthetic bone grafts. She has practical and academic experience in tissue engineering, electron microscopy and material characterisation systems including raman spectroscopy and fourier-transform infrared spectroscopy. She has also worked with clients seeking patent protection for their medical devices.

Qualifications

Patent Attorney

Chartered (UK)
European


MENG

Materials Engineering in Medicine

PHD

Biomaterials

Publications

UK Supreme Court Reaches a Unanimous decision in Parallel Unwired Planet and Conversant Appeal cases, Spelling Victory for Standard Essential Patent Holders

View publication online

Conferences: 2021

December 9th 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

Speaker

Event details

May 25th 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 29th September 2022

North East Automotive Expo 2022

HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …

Event details
Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.